Summit Royalties Ltd. has promoted Kathy Lai to Chief Financial Officer and Corporate Secretary, effective November 1, 2026. She replaces Robert Doyle, who led the company through its public listing and significant growth, including the acquisition of Star Royalties Ltd. Lai, with over 20 years of financial experience, joined Summit in July 2026 from Star Royalties. Doyle will remain until December 2026 to ensure a smooth transition. This leadership change supports Summit's strategy of disciplined growth through acquisitions and cash flow expansion.
Summit Royalties leadership change provides context for readers. For those tracking Basic Materials, here is Pluang's market snapshot as of Nov 02, 2026 19:41 WIB: 64 of 83 US stocks rose, 10 fell. Notable movers include SVM at USD 8.16 (+2.84%), HMY at USD 14.84 (+2.70%), and EQX at USD 9.95 (+2.58%). Typical hold times range from 14 to 46 days.
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
